Side effects (nausea, constipation, vomiting) that worsen after week 3 should be reported promptly
These presentations may indicate conditions requiring investigation, including thyroid disorders, cardiovascular issues, pancreatitis, gallbladder disease, or other endocrine abnormalities
As far as cost goes, even though we cant control the price of medications, we do strive to keep our own prices as low as possible
GLP-1 RAs (like Ozempic and Wegovy ) and dual GLP-1/GIP RAs (like Mounjaro and Zepbound ) mimic natural gut hormones
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: incidence and consequences
Multiple risk factors compound vulnerability : PCOS (50% lower glutathione), IVF (70-83% depleted antioxidants), gallbladder dysfunction (10%), choline deficiency (89%), poor diet, and chemical exposures